Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register

by Paloma Vela, Carlos Sanchez-Piedra, Carolina Perez-Garcia, María C. Castro-Villegas, Mercedes Freire, Lourdes Mateo, Cesar Díaz-Torné, Cristina Bohorquez, Juan M. Blanco-Madrigal, Inmaculada Ros-Vilamajo, Silvia Gómez, Rocio Caño, Fernando Sánchez-Alonso, Federico Díaz-González, Juan J. Gómez-Reino
Published 2020-06-01